Literature DB >> 7136917

Gangliosides and neutral glycosphingolipids in human brain tumors: specificity and their significance.

Y Eto, S Shinoda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7136917

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Ganglioside GD3 shedding by human gliomas.

Authors:  O Nakamura; M Iwamori; M Matsutani; K Takakura
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  Sex- and age-related differences in ceramide dihexosides of primary human brain tumors.

Authors:  A J Yates; T K Franklin; B W Scheithauer; P C Burger; D K Pearl
Journal:  Lipids       Date:  1999-01       Impact factor: 1.880

3.  Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas.

Authors:  M Blaszczyk; K Y Pak; M Herlyn; H F Sears; Z Steplewski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.

Authors:  K M Hedberg; B Dellheden; C J Wikstrand; P Fredman
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

5.  GD3 expression by cultured human tumor cells of neuroectodermal origin.

Authors:  X He; C J Wikstrand; P Fredman; J E Månsson; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Gangliosides in meningiomas: correlation of Glac2 to intermediary filament.

Authors:  G Pausch; R Jennemann; H D Mennel; B L Bauer; A F Rodden; H Wiegandt
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.